Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,294,594
-$3,487,488 QoQ
Shares Held
27,501
+2.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026HARBOUR INVESTMENTS, INC. holds $117,796,291 across 17 Drug Manufacturers - General names. LLY ranks #2 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
228,025 | $49,593,157 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
27,501 | $25,294,594 | |
| 3 | JNJ |
Johnson & Johnson
|
79,700 | $19,481,868 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,030 | $4,815,208 | |
| 5 | PFE |
Pfizer Inc
|
143,430 | $4,027,514 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,884 | $3,328,713 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
52,185 | $3,165,020 | |
| 8 | AMGN |
Amgen Inc
|
8,658 | $3,046,317 |
All Filings in LLY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,294,594 | 27,501 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $28,782,082 | 26,782 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $14,136,101 | 18,527 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $12,361,786 | 15,858 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $10,558,433 | 12,784 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $9,624,524 | 12,467 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $8,359,729 | 9,436 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $7,238,513 | 7,995 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $6,036,191 | 7,759 | Shares | Sole | 2024-07-22 | |
| 2023-12-31 | $4,414,453 | 7,573 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $3,371,027 | 6,276 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $3,201,257 | 6,826 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,284,086 | 6,651 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,392,227 | 6,539 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $1,111,030 | 3,436 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,114,054 | 3,436 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $2,284,891 | 8,272 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $2,337,532 | 10,117 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,624,561 | 11,435 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,168,606 | 11,608 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||